| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.00056 | 1 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00042 | 1 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.00039 | 1 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.00043 | 1 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.00035 | 1 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.00013 | 1 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.00028 | 1 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.00012 | 1 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.00016 | 1 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -7.8e-05 | 1 |